Marshall Wace North America’s Tandem Diabetes Care TNDM Stock Holding History

Marshall Wace North America’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,643	Closed	-$322K	–	1775
2021 Q1	$322K	Buy	3,643 +1,422	+64%	+$132K	﹤0.01%	1302
2020 Q4	$213K	Buy	+2,221	New	+$229K	﹤0.01%	1221
2020 Q1	–	Sell	-27,763	Closed	-$1.66M	–	1601
2019 Q4	$1.66M	Sell	27,763 -158,547	-85%	-$9.78M	0.01%	612
2019 Q3	$11M	Buy	186,310 +66,298	+55%	+$4.23M	0.06%	249
2019 Q2	$7.74M	Sell	120,012 -10,825	-8%	-$699K	0.05%	274
2019 Q1	$8.31M	Buy	130,837 +26,873	+26%	+$1.41M	0.06%	235
2018 Q4	$3.95M	Sell	103,964 -183,332	-64%	-$6.47M	0.04%	287
2018 Q3	$12.3M	Buy	+287,296	New	+$10M	0.08%	187
2018 Q2	–	Sell	-150,525	Closed	-$747K	–	1685
2018 Q1	$747K	Buy	+150,525	New	+$485K	﹤0.01%	1066

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Marshall Wace North America's TNDM Position: Q2 2021 in Review

Marshall Wace North America sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 3,643 shares — an estimated $322K sold.

Marshall Wace North America first reported a position in TNDM in Q1 2018 and held it in 9 quarters. The position peaked at $12.3M in Q3 2018. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

Marshall Wace North America reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 3,643 Tandem Diabetes Care shares in Q2 2021, an estimated $322K.
Marshall Wace North America first reported a position in Tandem Diabetes Care in Q1 2018 and held it in 9 quarters.
Marshall Wace North America's Tandem Diabetes Care position peaked at $12.3M in Q3 2018.
303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.